Are young women with Turner syndrome at greater risk of coronary artery disease?

European Journal of Preventive Cardiology

Volumn 13, Issue 3, 2006, Pages 467-469

  Kozlowska Wojciechowska, Malgorzata ^a   Jez, Waclaw ^b   Zdrojewski, Tomasz ^c   Chwojnicki, Kamil ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Outpatient Clinic for Turner Syndrome Patients   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

cardiovascular disease; risk factors; Turner syndrome

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEIGHT; HIGH RISK POPULATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POLAND; POPULATION RESEARCH; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH; TURNER SYNDROME;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; RISK FACTORS; TURNER SYNDROME; WAIST-HIP RATIO;

EID: 33748254929     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000216545.99807.fd     Document Type: Article

References (10)

1. Lippe B. Turner syndrome. Endocrinol Metab Clin North Am 1991; 20: 121–152.
2. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998; 101: E11.
3. Price WH, Clayton JF, Collyer S, De Mey R, Wilson J. Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health 1986; 40: 97–102.
4. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Pabunmi RP, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109: 672–693.
5. Gravholt CH. Turner syndrome and the heart: cardiovascular complications and treatment strategies. Am J Cardiovasc Drugs 2002; 2: 401–413.
6. Garden AS, Diver MJ, Fraser WD. Undiagnosed morbidity in adult women with Turner's syndrome. Clin Endocrinol (Oxf) 1996; 45: 589–594.
7. Elsheikh M, Dunger DB, Conway GS, Wass JAH. Turner's syndrome in adulthood. Endocrine Rev 2002; 23: 120–140.
8. Stangl V, Baumann G, Stangl K. Coronary atherogenic risk factor in women. Eur Heart J 2002; 23: 1738–1752.
9. Willett WC, Manson JE, Stampfer MJ. Weight, weight change, and coronary heart disease in women. JAMA 1995; 273: 461–465.
10. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998; 21: 1062–1070.